Regulatory pathways for registration of new drugs and generic drugs in China and United States (injectables and oral solid dosage forms)

By:

Language: English Publication details: 2019Edition: 1Description: 106pSubject(s):

DDC classification:

Dissertation note: Balamuralidhara VJSS AHERP.Regulatory Affairs

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Status	Barcode
Dissertation/Thesis	JSS College of Pharmacy, Mysuru	JSS College of Pharmacy, Mysuru	615.4 MAH (Browse shelf(Opens below))	Available	D11320

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.4 MAD Preparation and characterization of poly (2-hydroxyethyl methacrylate-Co-methyl methacrylate) hydrogels as sustained release drug delivery system	615.4 MAD Scale up and process validation of the manufacturing process for tablets of leukotriene receptor antagonist	615.4 MAH Controlled release of diltiazem HCL from chitosan gellan beads	615.4 MAH Regulatory pathways for registration of new drugs and generic drugs in China and United States (injectables and oral solid dosage forms)	615.4 MAH Good cosmetovigilance practice in Japan	615.4 MAH Regulatory requirements for controlled drugs and its impact on drug availability	615.4 MAL Validation of dry heat sterilizer	Next